Biospectrum Asia: "Startup Antidote raises £11m"

Antidote's funding news was covered in Biospectrum Asia this week. The article explains: 

"Antidote Technologies, a clinical trial matching platform, has raised £11m in a funding round led by Merck Global Health Innovation Fund (GHI) and joined by existing investors Smedvig Capital and Octopus Ventures.

Helping patients find medical trials online, the start-up has made 14,000 ‘matches’ to date, and plans to reach full coverage of US trials next year with added features, such as matching cancer patients to studies using mutation-level data."

Read more at Biospectrum Asia.